DSN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.46549439250521E-14 |
Normal-vs-Stage2 |
1.22949999958877E-07 |
Normal-vs-Stage3 |
5.24729999451523E-08 |
Normal-vs-Stage4 |
9.52793399733309E-12 |
Stage1-vs-Stage2 |
9.751200E-01 |
Stage1-vs-Stage3 |
6.712600E-01 |
Stage1-vs-Stage4 |
6.041800E-02 |
Stage2-vs-Stage3 |
7.224000E-01 |
Stage2-vs-Stage4 |
1.611600E-01 |
Stage3-vs-Stage4 |
3.081000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
2.5465999999863E-06 |
Normal-vs-Asian |
3.559900E-02 |
Caucasian-vs-AfricanAmerican |
2.169800E-01 |
Caucasian-vs-Asian |
2.272600E-01 |
AfricanAmerican-vs-Asian |
2.534200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62458935193399E-12 |
Normal-vs-Female |
1.66522351463527E-12 |
Male-vs-Female |
3.276200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.206800E-04 |
Normal-vs-Age(41-60Yrs) |
3.10862446895044E-15 |
Normal-vs-Age(61-80Yrs) |
1.63735691671718E-12 |
Normal-vs-Age(81-100Yrs) |
4.75200000005227E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.251000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.076600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.954400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.639800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.817800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.080800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.17849999994968E-06 |
Normal-vs-Grade 2 |
1.62769797640294E-12 |
Normal-vs-Grade 3 |
3.43614026121486E-12 |
Normal-vs-Grade 4 |
4.57299997869143E-09 |
Grade 1-vs-Grade 2 |
5.148000E-01 |
Grade 1-vs-Grade 3 |
6.940000E-01 |
Grade 1-vs-Grade 4 |
8.690800E-01 |
Grade 2-vs-Grade 3 |
8.525400E-01 |
Grade 2-vs-Grade 4 |
1.886810E-01 |
Grade 3-vs-Grade 4 |
2.551400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.63768998362457E-12 |
Normal-vs-ccB subtype |
2.47319942303648E-11 |
ccA subtype-vs-ccB subtype |
2.535200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.65933933260476E-12 |
Normal-vs-N1 |
5.74509999999862E-05 |
N0-vs-N1 |
1.014170E-01 |
|
|